Jan 10, 2023 The post Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2- Breast Cancer first appeared on Treadwell Therapeutics .
Need help?
Contact usJan 10, 2023 The post Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2- Breast Cancer first appeared on Treadwell Therapeutics .